Tech Company Financing Transactions
Trident Pharmaceuticals Funding Round
Trident Pharmaceuticals closed a $275.2 thousand funding round on 5/22/2014. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/22/2014
Transaction Type
Venture Equity
Amount
$275,187
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
184 High St.
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Not Recorded
Overview
Trident Pharmaceuticals, founded in 2006, is dedicated to the development of novel immunomodulatory drug products for the treatment of inflammatory and autoimmune disorders and allergic conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tom Needham
Chief Operating Officer
Alan Watt
Browse more venture capital transactions:
Prev: 5/22/2014: TRIA Beauty venture capital transaction
Next: 5/22/2014: Tackle Grab venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs